NCT04449185View on ClinicalTrials.gov

Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
Dyspepsia
Interventions
DRUG

Tegoprazan 50mg bid + amoxicillin 1000mg bid + clarithromycin 500mg bid for 10 days

Tegoprazan 50mg bid + amoxicillin 1000mg bid + clarithromycin 500mg bid for 10 days

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT04449185 - Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia | Biotech Hunter | Biotech Hunter